Sendaway capillary NT-proBNP in pulmonary hypertension
Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker of cardiac ventricular wall stress that is incorporated into pulmonary hypertension (PH) risk stratification models. Sendaway sampling may enable patients to perform NT-proBNP tests remotely. This UK-wide study aimed to...
Main Authors: | Eleanor Morris, Stephen J Wort, Martin K Johnson, James L Lordan, Daniel S Knight, Chloe Roddis, Charlotte Durrington, Harrison D Stubbs, John Cannon, Emily Knightbridge, Wendy Gin-Sing, Fiona Massey, Ruta Virsinskaite, Eleanor Sear, Joy Apple-Pinguel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-07-01
|
Series: | BMJ Open Respiratory Research |
Online Access: | https://bmjopenrespres.bmj.com/content/11/1/e002124.full |
Similar Items
-
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
by: Robert A. Lewis, et al.
Published: (2020-05-01) -
The integration of BNP and NT-proBNP into clinical medicine
by: Swiss Medical Weekly
Published: (2007-01-01) -
Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD
by: Benedikt Seither, et al.
Published: (2024-11-01) -
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
by: A Palazzuoli, et al.
Published: (2010-05-01) -
Highly sensitive detection of NT-proBNP by molecular motor
by: Jie Zhang, et al.
Published: (2017-03-01)